Search Results | MSF Science Portal

Science Portal

v2.1.5662.produseast1

About MSF Science Portal

About

Frequently Asked Questions (FAQs)

v2.1.5662.produseast1

Showing 1 - 4 of 4 Items

Sort By: Relevance

Newest to oldest
Oldest to newest
Relevance

Journal Article

Research

Journal Article

Research

Enhancing tuberculosis (TB) case detection among hospitalized patients through lay health worker led screening: a before-and-after study in KwaZulu-Natal, South Africa

Bulti AB, Dumicho AY, Shigayeva A, Van Cutsem G, Steele SJ, et al.

2025-04-23 • Scientific Reports

Tuberculosis (TB) among hospitalized patients is underdiagnosed. This study assessed systematic TB-screenin...

Journal Article

Pre-Print

Enhancing tuberculosis (TB) diagnosis among hospitalized patients in KwaZulu-Natal, South Africa: a before-and-after study of a lay health worker-driven intervention

Bulti AB, Dumicho AY, Shigayeva A, van Cutsem G, Steele SJ, et al.

2024-03-08 • Scientific Reports

BACKGROUND

Tuberculosis (TB) among hospitalized patients is underdiagnosed. This study assessed systematic TB-screen...

Journal Article

Research

Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis

Tack I, Dumicho A, Ohler L, Shigayeva A, Bulti AB, et al.

2020-12-29 • Clinical Infectious Diseases

Background
At the end of 2018, South Africa updated its all-oral regimen, to include bedaquiline (BDQ) and two months of linezolid (LZD) for all patients initiating the shorter 9 to...

Journal Article

Research

Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high Human Immunodeficiency Virus (HIV) burden rural South Africa: a retrospective cohort analysis

Tack I, Dumicho A, Ohler L, Shigayeva A, Bulti AB, et al.

2021-11-02 • Clinical Infectious Diseases

BACKGROUND
At the end of 2018, South Africa updated its all-oral regimen to include bedaquiline (BDQ) and 2 months of linezolid (LZD) for all patients initiating the shorter 9-12 mon...